Vascular function modulation

"Vascular function modulation" is not a single molecule, receptor, or protein but rather a broad physiological or pharmacological concept that refers to the regulation of the functional properties of blood vessels—such as contraction, relaxation, elasticity, and remodeling—primarily through the activity of vascular smooth muscle cells and endothelial cells. Vascular function is central to the control of blood pressure and the development of hypertension, heart failure, and other cardiovascular diseases. Modulation of vascular function often targets multiple signaling pathways, including but not limited to, the nitric oxide (NO)-cGMP pathway, calcium signaling, and the renin-angiotensin-aldosterone system. Therapeutic interventions that impact vascular function include a range of pharmacological agents (e.g., beta-blockers, ACE inhibitors, angiotensin II receptor antagonists, diuretics), device-based treatments, and gene therapies; however, these interventions target molecules or pathways rather than "vascular function modulation" itself[2][1][3]. Therefore, "vascular function modulation" is not a canonical drug target but an umbrella term for a set of interconnected pathways and physiological processes.